Category Archives: Jalyn

Featured Stories

Johnson & Johnson’s Ethicon Division to End Sales of Gynecare Prolift, Three Other Transvaginal Mesh Devices

Johnson & Johnson’s Ethicon Inc. division revealed yesterday that it will end sales of its Gynecare Prolift device and three other transvaginal mesh products. The plan to stop selling the four products was set forth in a letter filed by the company in the Ethicon transvaginal mesh multidistrict litigation ...

Read More

Cancer Groups Call for E-cigarettes Regulation/Research

Two Leading Cancer Groups Issue Call for Regulation of E-cigarettes and Research on Health Risks

In a joint statement, the American Society of Clinical Oncology and the American Association for Cancer Research have called on the federal government to move quickly to regulate e-cigarettes and increase research on their health effects. These leading research and treatment organizations asked the Food and Drug Administration (FDA) to make ...

Read More

British Health Agency Strengthens Warnings about Valproate

British Health Agency Strengthens Warnings about Valproate Risk in Pregnancy

Statement issued urging healthcare professionals to give women information on birth defects when Depakote and other valproate medicines are used during pregnancy.

Read More

Exposure to Common Pesticide May Increase ADHD Risk

Exposure to Common Pesticide May Increase ADHD Risk

A new study has found that exposure to a common household pesticide may increase the risk of attention deficit hyperactivity disorder (ADHD) in children.

Read More

Birth Control Shot Depo-Provera may Increase HIV Risk

Birth Control Shot Depo-Provera may Increase HIV Risk, Study Suggests

A new study has linked the use of Depo-Provera (medroxyprogesterone acetate), an injectable type of birth control, to an increased risk of HIV infection.

Read More

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

Toxic Nano-Particles from Failing Metal-on-Metal Hip Replacements May Pose Long-Term Health Risks

According to a new study, failing metal-on-metal hip implants generate toxic nano-particles that release Cobalt 2+ ions, which not only cause inflammation in surrounding tissue, but have the potential to cause long-term damage to the genetic material of cells. According to a report published by Medicalxpress.com, this “genotoxicity” could ...

Read More

Former Executives Accuse Health Technology Firm of Fraud

Former Executives Accuse Health Technology Firm of Fraud

Former NantHealth executives claim that the company made fraudulent claims about the reliability of its system, which links patient information gathered by the devices.

Read More

Majority of Metal-on-Metal Hip Implant Failures Occur within Two Years, Study Finds

A newly published metal-on-metal hip replacement study is reporting that the majority of failures occur early, within two years of surgery. The study, published in the journal Orthopedics, is just the latest to indicate that close follow-up of metal-on-metal hip implant patients is warranted.

Read More

Health Canada Issues Warning For Proscar, Propecia, Avodart, and Jalyn

Health Canada has issued a warning about Proscar, Propecia, Avodart, and Jalyn, medications prescribed for the treatment of enlarged prostate or mail-pattern baldness. The drugs may increase risks for a serious type of prostate cancer, said Health Canada, wrote the … Continue reading

Posted in Avodart, Jalyn, Pharmaceuticals, Propecia, Proscar |

Stay Away from Avodart, Public Citizen Warns

The consumer advocacy group, Public Citizen, has warned men to avoid taking < "http://www.yourlawyer.com/topics/overview/Avodart-Prostate-Cancer-Side-Effects-Lawsuit">Avodart (dutasteride), a drug used to treat enlarged prostate. According to the group, other treatments, including a class of drug known as alpha blockers, are often safer … Continue reading

Posted in Avodart, Jalyn, Pharmaceuticals, Propecia, Proscar |

Baldness, Prostate Drugs May Cause Persistent Erectile Dysfunction

Erectile dysfunction is a known side effect of < "http://www.yourlawyer.com/topics/overview/Propecia-Prostate-Cancer-Side-Effects-Lawsuit">Propecia, < "http://www.yourlawyer.com/topics/overview/Proscar-Prostate-Cancer-Side-Effects-Lawsuit">Proscar, < "http://www.yourlawyer.com/topics/overview/Avodart-Prostate-Cancer-Side-Effects-Lawsuit">Avodart or < "http://www.yourlawyer.com/topics/overview/Jalyn-Prostate-Cancer-Side-Effects-Lawsuit">Jalyn. But recent research out of Boston University indicates that in some cases, sexual dysfunction linked to these drugs could be irreversible, Propecia and … Continue reading

Posted in Avodart, Jalyn, Pharmaceuticals, Propecia, Proscar |

Proscar, Propecia Breast Cancer Reports Prompt Label Change in Canada

Health Canada announced yesterday that the manufacturers of finasteride products, including Propecia, < "http://www.yourlawyer.com/topics/overview/Proscar-Prostate-Cancer-Side-Effects-Lawsuit">Proscar and their generic equivalents, are updating the drugs’ labels to add safety information on rare reports of breast cancer in men. Patients taking Proscar, < "http://www.yourlawyer.com/topics/overview/Propecia-Prostate-Cancer-Side-Effects-Lawsuit">Propecia … Continue reading

Posted in Avodart, Jalyn, Pharmaceuticals, Propecia, Proscar |

FDA Warns Drugs for Enlarged Prostate, Hair Loss May Increase Risk of Aggressive Prostate Cancer

The U.S. Food & Drug Administration (FDA) announced yesterday that new warnings will be added to labels of < "http://www.yourlawyer.com/topics/overview/5-alpha-Reductase-Inhibitor-Proscar-Propecia-Avodart-Jalyn-Prostate-Cancer-Lawsuit">Proscar, Avodart, Jalyn and Propecia regarding a possible association with high-grade prostate cancer. Proscar, Avodart and Jalyn are all used to … Continue reading

Posted in Avodart, Jalyn, Legal News, Pharmaceuticals, Propecia, Proscar |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.